To identify molecular mechanisms accounting for SHP2i-mediated PI3K pathway activation, we quantified the total tyrosyl-phosphorylation of 39 RTKs in tumor protein lysates from SHP2i-treated tumors (Fig. 3A, B). The gene discussed is PIK3CA; the disease is neoplasm.